Ads
-
Related paper
- Mirabegron: first β3 agonist in treatment of overactive bladder
- Pharmacologic Management of Overactive Bladder and Urge Incontinence: A Review of New and Old Treatment Options
- FORMULATION AND EVALUATION OF MODIFIED RELEASE MATRIX TABLETS OF TOLTERODINE TARTRATE FOR TREATMENT OF OVERACTIVE BLADDER DISEASE
- Urinary Incontinence and Overactive Bladder Syndrome Impact on Quality of Women Sexual Life
- Posterior Tibial Nerve Stimulation, Is It Effective Method in Managing Overactive Bladder Symptoms?
- METHOD OF RADICAL CYSTECTOMY WITH PRESERVATION OF PROSTATIC CAPSULE WITH ORTHOTOPIC PLASTY OF URINARY BLADDER IN TREATMENT FOR BLADDER CANCER
- Lorcaserin: a selective serotonin receptor (5-HT2C) agonist for the treatment of obesity
- Farnesoid X Receptor Agonist as a new treatment option for Non-Alcoholic Fatty Liver disease: A Review
- The Effect of Denervation and Treatment with the ß2-Agonist, Formoterol, on the Masseter Muscles of Growing Sprague Dawley Rats
- CONSEQUENCES OF DOPAMINERGIC AGONIST ASSOCIATED WITH BDNF TREATMENT ON BEHAVIORAL ALTERATIONS AND CYTOLOGICAL CHANGES IN AN EXPERIMENTAL MODEL OF PARKINSON DISEASE DUE TO MANGANESE EXPOSURE